Bioorganic and Medicinal Chemistry Letters p. 983 - 987 (2004)
Update date:2022-08-05
Topics:
Zhang, Penglie
Bao, Liang
Zuckett, Jingmei F.
Goldman, Erick A.
Jia, Zhaozhong J.
Arfsten, Ann
Edwards, Susan
Sinha, Uma
Hutchaleelaha, Athiwat
Park, Gary
Lambing, Joseph L.
Hollenbach, Stanley J.
Scarborough, Robert M.
Zhu, Bing-Yan
Anthranilamides 4 and 5 were designed and synthesized as selective and orally bioavailable factor Xa inhibitors. Structural modifications aimed at lowering their lipophilicity were performed at the central phenyl ring and at the S4 binding biphenyl region by incorporating water solublizing substituents. The resulting compounds (e.g., 7, 8, 14, 30a, and 32b) are highly potent in vitro, and show improved activity in human plasma-based thrombin generation assay.
View MoreNantong LiKai Chemical Co.,Ltd
Contact:+86-513-89068669
Address:Jincheng Science Park
Contact:732.938.2777
Address:5012 Industrial Road Farmingdale, NJ 07727
Shandong General Materials Co.,Ltd(Shandong Aoertong Chemical Co., Ltd)
Contact:86-531-88072280
Address:No. 1825 Hualong Road, Licheng District, Jinan, Shandong, China
Hefei EnliPharma Tecnology Co.,Ltd
Contact:0086-551-66399836
Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei
Contact:021
Address:Pudong
Doi:10.1246/bcsj.51.2415
(1978)Doi:10.1107/S0108270100002729
(2000)Doi:10.1007/BF00504194
(1985)Doi:10.1021/ol502578h
(2014)Doi:10.1055/s-2004-815929
(2004)Doi:10.1021/jo035482m
(2004)